As per the recently published report by MarketsandMarkets™, The report "HLA Typing Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) & Region - Global Forecast to 2028", is projected to reach USD 2.1 billion by 2028 from an estimated value of USD 1.4 billion in 2022, at a CAGR of 6.5% during the forecast period.
Download PDF Brochure: -
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39129877
Browse
- 180
Market Data Tables
- 37
Figures
- 223
Pages and in-depth TOC on " HLA Typing Market - Global Forecast
to 2028”
Some of the prominent key players are:
- Bio-Rad
Laboratories, Inc. (US),
- F.
Hoffmann-La Roche Ltd. (Switzerland),
- QIAGEN
N.V. (Netherlands),
- Thermo
Fisher Scientific Inc. (US),
- bioMérieux
S.A. (France) and many more......
Mergers
& acquisitions, investments & expansions, partnerships &
collaborations, and new product developments are some of the major strategies
adopted by these key players to enhance their positions in the HLA Typing
Market.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=39129877
- Based
on technology, the HLA typing market is segmented into molecular assay
technologies and non-molecular assay technologies. The molecular assay
technologies segment accounted for the largest market share in 2022.
- Molecular
assay techniques are used in HLA typing for applications such as
donor-recipient cross-matching, cancer and autoimmune disease diagnostics,
infectious disease diagnostics, and transfusion.
- Based
on application, the diagnostic applications market is segmented into
donor-recipient match, Cancer Diagnosis and prevention, Infectious and
non-infectious disease testing, Transfusion Therapy and Others. The
diagnostic applications segment accounted for the highest CAGR of 6.5%
during the forecast period.
- Based
on the region, the HLA Typing Market is segmented into North America,
Europe, Asia Pacific, Latin America and Middle East & Africa. North
America accounted for the largest share of the HLA Typing Market.
Recent Developments:
- In March 2023, BioRad received
The company received AOAC International and AFNOR approval for its
iQ-Check kits, which are used with the CFX Opus Deepwell Real-time PCR
System
- In August 2022 Roche developed a
new digital Light cycler system that helps determine a patient’s cancer.
- In May 2022, CareDx received CE
marking for its AlloSeq HCT chimerism testing kit and AlloSeq HCT
software. These AlloSeq are used in patients who have received
Hematopoietic cell transplantation.
No comments:
Post a Comment